Lava Therapeutics NVLVTX
13F holders, Q4 2024 (December 31)22holders +1
4new positions
7sold out
1famous investor
$0.95avg. 13F price*
At the end of Q4 2024, 22 institutions reported holding Lava Therapeutics NV (LVTX) in their 13F filings, up 1 from Q3 2024. 4 opened new positions and 7 sold out. The largest holders were Redmile Group, LLC ($2.0M), Sanofi ($1.8M) and Merck & Co., Inc. ($1.1M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Lava Therapeutics NV
- CUSIP
- N51517105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $68K |
| Exits | 7 | $411K |
All 13F filers, Q3 2024 → Q4 2024: 123,661 shares bought and 349,452 shares sold, net −225,791 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Redmile Group, LLC | 0.14% | No change | 2,074,372 | $2.0M |
| Sanofi | 1.05% | — | 1,919,455 | $1.8M |
| Merck & Co., Inc. | 0.42% | — | 1,149,345 | $1.1M |
| Bruce & Co., Inc. | 0.24% | No change | 771,874 | $733K |
| Sphera Funds Management LTD. | 0.02% | Reduce -13.7% | 126,328 | $120K |
| Pathway Financial Advisors LLC | 0.02% | No change | 102,500 | $97K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 65,000 | $62K |
| Two Sigma Investments, LP | 0.00% | Reduce -52.5% | 48,772 | $46K |
| BNP Paribas Financial Markets | 0.00% | New | 41,800 | $40K |
| Engineers Gate Manager LP | 0.00% | Add +169.0% | 31,985 | $30K |
| Diadema Partners LP | 0.02% | — | 21,508 | $20K |
| Virtu Financial LLC | 0.00% | Add +4.3% | 19,916 | $19K |
| Millennium Management | 0.00% | Add +62.5% | 19,604 | $19K |
| UBS Group AG | 0.00% | Add +1619.3% | 18,431 | $18K |
| HRT Financial LP | 0.00% | New | 17,836 | $16K |
| Geode Capital Management, LLC | 0.00% | Add +45.3% | 16,164 | $15K |
| Two Sigma Securities, LLC | 0.00% | New | 13,157 | $13K |
| Morgan Stanley | 0.00% | Reduce -76.7% | 8,500 | $8K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 6,000 | $6K |
| SBI Securities Co., Ltd. | 0.00% | — | 300 | $285 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 20 | $19 |
| Tsfg, LLC | 0.00% | No change | 400 | $0 |
"% of holder's portfolio" is LVTX's weight in each manager's 13F, not the share of Lava Therapeutics NV the manager owns.